Daniel Gallagher, a former commissioner with the U.S. Securities and Exchange Commission whose background includes stints in the financial services and pharmaceuticals industries, is returning to Wilmer Cutler Pickering Hale and Dorr as a partner.
For the last two years Gallagher has been chief legal officer at Mylan, a leading generic drug maker. He plans to leave Mylan in April and to begin practicing out of Wilmer’s Washington, D.C., and New York offices after Labor Day, serving as deputy chair of the firm’s securities department.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]